NCT00388440View on ClinicalTrials.gov

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

PHASE4CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

April 30, 2001

Study Completion Date

April 30, 2001

Conditions

RubellaMumpsMeasles

Interventions

BIOLOGICAL

MMR vaccine (Priorix)

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00388440 - Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. | Biotech Hunter | Biotech Hunter